Aripiprazole
Aribit contains the active substance aripiprazole and belongs to a group of medicines called antipsychotics.
It is used in the treatment of adults and adolescents aged 15 years and older with schizophrenia - a disease characterized by symptoms such as: seeing, hearing, and feeling things that do not exist in reality, excessive suspiciousness, beliefs that are inconsistent with reality, incoherent speech and behavior, and emotional numbness. Patients may also experience sadness, anxiety, or tension, as well as feelings of guilt.
Aribit is used in adults and adolescents aged 13 years and older in the treatment of manic episodes, with symptoms such as: strong excitement, overflowing energy, reduced need for sleep, very rapid speech, racing thoughts, and sometimes very severe irritability. In adults, this medicine also prevents the recurrence of the above symptoms in patients who have responded to treatment with Aribit.
Before starting to take Aribit, you should discuss this with your doctor.
During treatment with aripiprazole, thoughts and behaviors of suicide have been reported. You should immediately inform your doctor if you experience thoughts or feelings related to self-harm.
Before starting treatment with Aribit, you should tell your doctor if you have:
If you notice an increase in weight, appearance of unusual movements, drowsiness that interferes with your daily activities, any difficulty swallowing, or symptoms of an allergy, you should inform your doctor.
If you are an elderly patient with dementia, you or your caregiver should inform your doctor if you have ever had a stroke or "mini" stroke.
You should immediately inform your doctor if you experience thoughts or feelings related to self-harm. During treatment with aripiprazole, thoughts and behaviors of suicide have been reported.
You should immediately inform your doctor if you experience muscle stiffness or muscle stiffness with high fever, sweating, mental disorders, or very rapid or irregular heartbeat.
If you or your family member or caregiver notice that you start to feel the urge or desire to behave in an unusual way, and that you cannot resist the impulse, drive, or temptation to engage in activities that may harm you or others, you should tell your doctor. These phenomena are called impulse control disorders and may manifest as behaviors such as:
Your doctor may decide to change the dose or discontinue the medicine.
Aripiprazole may cause drowsiness, decreased blood pressure when standing up, dizziness, and changes in mobility and balance, which may lead to falls. You should be careful, especially if you are an elderly or weakened patient.
Aribit should not be used in children and adolescents under 13 years of age. It is not known if the use of the medicine is safe and effective in these patients.
You should tell your doctor or pharmacist about all medicines you are currently taking or have recently taken, as well as any medicines you plan to take, including those that are available without a prescription.
Blood pressure-lowering medicines: Aribit may enhance the effects of blood pressure-lowering medicines.
If you are taking blood pressure-lowering medicines, you should inform your doctor.
Taking Aribit with certain medicines may require a change in the dose of Aribit or other medicines you are taking. It is especially important to inform your doctor about taking:
Taking these medicines may increase the risk of side effects or reduce the effect of Aribit. If you experience any unusual symptoms while taking these medicines with Aribit, you should tell your doctor.
Medicines that increase serotonin levels are usually used in diseases including depression, generalized anxiety disorder, obsessive-compulsive disorder (OCD), and social phobia, as well as migraine and pain:
Taking these medicines may increase the risk of side effects. If you experience any unusual symptoms while taking these medicines with Aribit, you should tell your doctor.
The medicine can be taken with or without food.
You should avoid drinking alcohol.
If you are pregnant or breastfeeding, think you may be pregnant, or plan to have a child, you should consult your doctor or pharmacist before taking this medicine.
In newborns whose mothers took Aribit during the last trimester (last 3 months of pregnancy), the following symptoms may occur: trembling, muscle stiffness, and (or) weakness, drowsiness, agitation, difficulty breathing, and difficulty feeding. If you notice such symptoms in your child, you should contact your doctor.
If you are taking Aribit, your doctor will discuss with you whether you should breastfeed, considering the benefits of treatment and the benefits of breastfeeding. You should not take the medicine and breastfeed. You should discuss with your doctor the best methods for feeding your child if you are taking this medicine.
During treatment with this medicine, dizziness and vision disturbances may occur (see section 4).
You should take this into account when performing tasks that require full concentration, such as driving or operating machinery.
If you have been diagnosed with intolerance to some sugars, you should contact your doctor before taking the medicine.
This medicine should always be taken exactly as your doctor or pharmacist has told you. If you are not sure, you should ask your doctor or pharmacist.
The recommended dose of Aribit for adults is 15 mg once a day.Your doctor may, however, prescribe a lower or higher dose, up to a maximum of 30 mg once a day.
Treatment with Aribit may be started with a low dose of aripiprazole in the form of an oral solution (liquid) available on the market. The dose may be gradually increased to the recommended dose for adolescents of 10 mg once a day. Your doctor may, however, prescribe a lower or higher dose, up to a maximum of 30 mg once a day.
If you feel that the effect of Aribit is too strong or too weak, you should consult your doctor or pharmacist.
Aribit should be taken once a day at the same time.It does not matter whether the tablet is taken with or without food. The tablet should be swallowed whole and washed down with water.
Even if you feel better, you should not change the dose or stop taking Aribit without first discussing it with your doctor.
If you have taken more Aribit than your doctor recommended (or if someone else has taken your Aribit tablets), you should immediately contact your doctor or go to the nearest hospital, taking the medicine pack with you.
In patients who have taken too much aripiprazole, the following symptoms have occurred:
Other symptoms may include:
If you experience any of these symptoms, you should immediately contact your doctor or hospital.
If you miss a dose, you should take the missed dose as soon as you remember. You should not take two doses on the same day.
You should not stop treatment if you feel better.
It is very important to take Aribit exactly as your doctor has told you and for as long as your doctor has told you.
If you have any further questions about the use of this medicine, you should ask your doctor or pharmacist.
Like all medicines, Aribit can cause side effects, although not everybody gets them.
Common side effects (may affect up to 1 in 10 people):
Uncommon side effects (may affect up to 1 in 100 people):
The following side effects have been reported after the marketing of aripiprazole, but the frequency of their occurrence is not known (the frequency cannot be estimated from the available data):
In elderly patients with dementia taking aripiprazole, more cases of death have been reported. Additionally, cases of stroke or "mini" stroke have been recorded.
In adolescents aged 13 years and older, side effects occurred with a similar frequency and type as in adults, with the exception of drowsiness, uncontrolled trembling or movements, restlessness, and fatigue, which occurred very frequently (more than 1 in 10 patients), as well as upper abdominal pain, dry mouth, increased heart rate, weight gain, increased appetite, muscle tremors, uncontrolled limb movements, and dizziness, especially when standing up from a lying or sitting position, which occurred frequently (more than 1 in 100 patients).
If you experience any side effects, including those not listed in this leaflet, you should tell your doctor or pharmacist. Side effects can be reported directly to the Department of Drug Safety Monitoring of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products
Al. Jerozolimskie 181C
02-222 Warsaw
Phone: +48 22 49 21 301
Fax: +48 22 49 21 309
Website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
By reporting side effects, you can help provide more information on the safety of this medicine.
Store in a temperature below 30°C.
The medicine should be stored out of sight and reach of children.
Do not use this medicine after the expiry date stated on the blister and carton after: EXP.
The expiry date refers to the last day of the month.
The inscription on the packaging after the abbreviation EXP means the expiry date, and after the abbreviation Lot/LOT means the batch number.
Medicines should not be disposed of via wastewater or household waste. You should ask your pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
Aribit 5 mg tablets: each tablet contains 5 mg of aripiprazole.
Aribit 10 mg tablets: each tablet contains 10 mg of aripiprazole.
Aribit 15 mg tablets: each tablet contains 15 mg of aripiprazole.
Aribit 30 mg tablets: each tablet contains 30 mg of aripiprazole.
Aribit 5 mg: tablets are oblong, flat on both sides, light yellow in color, with slight notches allowed.
Aribit 10 mg: tablets are oblong, flat on both sides, light pink in color, with slight notches allowed.
Aribit 15 mg: tablets are round, flat on both sides, light yellow in color, with slight notches allowed.
Aribit 30 mg: tablets are round, convex on both sides, light pink in color, with slight notches allowed.
The medicine is available in Aluminum/OPA/Aluminum/PVC blisters containing 14, 28, 49, 56, or 98 tablets, in a cardboard box.
Not all pack sizes may be marketed.
Polpharma S.A.
Pelplińska 19, 83-200 Starogard Gdański
phone: +48 22 364 61 01
Polpharma S.A.
Pelplińska 19, 83-200 Starogard Gdański
Aribit 10 mg, 15 mg, 30 mg
Polpharma S.A.
Production Plant in Nowa Dęba
Metalowca 2, 39-460 Nowa Dęba
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.